Roth Capital Forecasts Weaker Earnings for Zimmer Biomet
Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) – Equities research analysts at Roth Capital cut their Q2 2025 earnings per share estimates for shares of Zimmer Biomet in a research note issued on Tuesday, May 6th. Roth Capital analyst J. Wittes now forecasts that the medical equipment provider will post earnings per share of […]
